Clinical trial PULSE
Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study (PULSE).
| Organ | Lung |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Oui |
| Sponsor | Institut Gustave Roussy |
| EudraCT Identifier | 2023-503481-23-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05692999 |
| Last update |